Infect Dis Clin North Am. 2021 Mar;35(1):157-167. doi: 10.1016/j.idc.2020.10.008. Epub 2020 Dec 7.
ABSTRACT
Skin and soft tissue infections (SSTIs) frequently are encountered in clinical practice, and gram-negative bacilli (GNB) constitute an underrated portion of their etiology. The rate of GNB-causing SSTIs is increasing, especially with the rise in antimicrobial resistance. Although the diagnosis of SSTIs mostly is clinical, rapid diagnostic modalities can shorten the time to initiating proper therapy and improving outcomes. Novel antibiotics are active against GNB SSTIs and can be of great value in the management. This review provides an overview of the role of GNB in SSTIs and summarizes their epidemiology, risk factors, outcome, and clinical management.
PMID:33303333 | DOI:10.1016/j.idc.2020.10.008